Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Chuan Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0642-3154; OpenAlex author ID A5100320825. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. Utidelone suppresses PDAC growth and enhances gemcitabine therapy by inducing immunogenic cell death. Co-author DOI 10.1016/j.isci.2025.112509↗
  2. Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer. First author DOI 10.3389/fonc.2022.964115↗
  3. Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma. Last author DOI 10.1016/j.intimp.2020.107359↗
  4. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer. Co-author DOI 10.1007/s10620-017-4641-8↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haitao Gu · 1 shared paper, 2025 · strength 0.25
  2. Qi Li · 1 shared paper, 2025 · strength 0.25
  3. Jingyi Zhou · 1 shared paper, 2025 · strength 0.25
  4. Long Jiang · 1 shared paper, 2025 · strength 0.25
  5. Fei Zhou · 1 shared paper, 2022 · strength 0.16
  6. Feifei Shen · 1 shared paper, 2022 · strength 0.16
  7. Bo Chen · 1 shared paper, 2021 · strength 0.15
  8. Yeqing Zou · 1 shared paper, 2017 · strength 0.07
  9. Bo Huang · 1 shared paper, 2017 · strength 0.07
  10. Xiaowei Fu · 1 shared paper, 2017 · strength 0.07
  11. Zhiwei Zhong · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.